Mycosyst (Fluconazole)

Fluconazole, the active ingredient in Mycosyst, is a systemic antifungal presented as an oral dosage form for oral use. It treats a range of fungal infections, including various forms of candidiasis and cryptococcal meningitis, in adult and pediatric patients as prescribed.

GNH USA supplies Mycosyst as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution, including temperature‑controlled shipping where required.

Fluconazole is used to treat fungal infections affecting the mucous membranes, systemic circulation, and central nervous system.

- Candidiasis (oropharyngeal, esophageal, vaginal): Reduces fungal load and resolves symptoms in affected mucosal sites. - Systemic candidiasis: Eradicates bloodstream and deep‑tissue Candida infections. - Cryptococcal meningitis: Controls fungal proliferation in the cerebrospinal fluid and improves clinical outcomes.

Fluconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea - Abdominal pain - Headache - Diarrhea - Rash - Elevated liver enzymes

Serious or Rare Side Effects: - Hepatotoxicity - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Anaphylactic reactions - QT interval prolongation - Severe liver injury - Blood dyscrasias (e.g., neutropenia, thrombocytopenia)

Before initiating Mycosyst, clinicians should consider several precautionary measures to ensure safe use.

- Assess liver function: Obtain baseline hepatic enzymes and monitor periodically. - Review concomitant medications: Identify potential drug‑drug interactions. - Monitor renal function: Adjust dose in patients with severe renal impairment. - Evaluate hypersensitivity: Discontinue if allergic reaction occurs. - Pregnancy and lactation: Weigh benefits against risks; use only if clearly indicated. - Store at ambient temperature: Keep below 25 °C in original packaging, protect from moisture.

Fluconazole interacts with several medicines; awareness of the interaction level guides clinical management.

Major Interactions (Avoid): - Rifampin: Significantly reduces fluconazole plasma concentrations. - Phenytoin: Decreases fluconazole exposure and may increase seizure risk. - Carbamazepine: Lowers fluconazole levels, compromising efficacy. - Voriconazole or other azoles: Combined use can increase toxicity.

Moderate Interactions (Monitor Closely): - Warfarin: Fluconazole can increase INR; monitor coagulation parameters. - Oral hypoglycemics (e.g., sulfonylureas): May enhance glucose‑lowering effect; check blood sugar. - Statins (especially simvastatin): Increased risk of myopathy; consider dose adjustment.